Inventor · disambiguated record
Qin Jiang
Also filed as: JIANG QIN
17 granted patents·3 pending applications·91 citations·filing 2002–2022
92Inventor score
Files withACUCELA INC5AGENEBIO INC3EOLAS THERAPEUTICS INC3UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION2ASLANIAN ROBERT G1
Top patents by PatentIndex Score
20 records- 0191US12291535B2Benzodiazepine derivatives, compositions, and methods for treating cognitive impairmentAGENEBIO INC·Filed 2022·Granted May 6, 2025·2 cites·37 claims
- 0286US8383793B2Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitorsST JUDE CHILDRENS RES HOSPITAL·Filed 2010·Granted Feb 26, 2013·8 cites·6 claims
- 0385US9440982B2Substituted prolines/piperidines as orexin receptor antagonistsEOLAS THERAPEUTICS INC·Filed 2014·Granted Sep 13, 2016·5 cites·26 claims
- 0484US8420863B2Styrenyl derivative compounds for treating ophthalmic diseases and disordersSCOTT IAN LESLIE·Filed 2012·Granted Apr 16, 2013·5 cites·17 claims
- 0583US9896452B2Substituted prolines/piperidines as orexin receptor antagonistsEOLAS THERAPEUTICS INC·Filed 2016·Granted Feb 20, 2018·5 cites·23 claims
- 0683US9499517B2Substituted prolines / piperidines as orexin receptor antagonistsEOLAS THERAPEUTICS INC·Filed 2014·Granted Nov 22, 2016·7 cites·12 claims
- 0782US6924284B2PARP inhibitorsDELTAGEN RES LABS LLC·Filed 2002·Granted Aug 2, 2005·42 cites·55 claims
- 0881US11220479B2Glucosylceramide synthase inhibitors and therapeutic methods using the sameUNIV MICHIGAN REGENTS·Filed 2020·Granted Jan 11, 2022·1 cites·20 claims
- 0980US9421210B2Styrenyl derivative compounds for treating ophthalmic diseases and disordersACUCELA INC·Filed 2015·Granted Aug 23, 2016·2 cites·18 claims
- 1079US9458508B2Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitorsST JUDE CHILDREN'S RES HOSPITAL·Filed 2013·Granted Oct 4, 2016·2 cites·10 claims
- 1178US8927559B2Quinazolinone-type compounds as CRTH2 antagonistsASLANIAN ROBERT G·Filed 2011·Granted Jan 6, 2015·6 cites·16 claims
- 1273US9416141B2Compounds and methods for preventing, treating and/or protecting against sensory hair cell deathUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2013·Granted Aug 16, 2016·1 cites·20 claims
- 1372US9902738B2Compounds and methods for preventing, treating and/or protecting against sensory hair cell deathUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2016·Granted Feb 27, 2018·1 cites·20 claims
- 1472US9469615B2Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulatorsBOYCE CHRISTOPHER W·Filed 2011·Granted Oct 18, 2016·4 cites·27 claims
- 1566US2009170841A1Styrenyl Derivative Compounds for Treating Ophthalmic Diseases and DisordersACUCELA INC·Filed 2008·Application pending·0 cites
- 1660US11414425B2Benzodiazepine derivatives, compositions, and methods for treating cognitive impairmentAGENEBIO INC·Filed 2019·Granted Aug 16, 2022·0 cites·51 claims
- 1760US2016193160A1Styrenyl Derivative Compounds for Treating Ophthalmic Diseases and DisordersACUCELA INC·Filed 2016·Application pending·0 cites
- 1858US10201545B2Styrenyl derivative compounds for treating ophthalmic diseases and disordersACUCELA INC·Filed 2015·Granted Feb 12, 2019·0 cites·4 claims
- 1957US9314467B2Styrenyl derivative compounds for treating ophthalmic diseases and disordersACUCELA INC·Filed 2015·Granted Apr 19, 2016·0 cites·11 claims
- 2051US2023098667A1Benzodiazepine derivatives, compositions, and methods for treating cognitive impairmentAGENEBIO INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Qin Jiang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →